|
MTAP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.591700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.861820E-02 |
| Normal-vs-Stage2 |
3.902900E-03 |
| Normal-vs-Stage3 |
9.92839999991446E-07 |
| Normal-vs-Stage4 |
1.566880E-04 |
| Stage1-vs-Stage2 |
1.302990E-01 |
| Stage1-vs-Stage3 |
7.976600E-04 |
| Stage1-vs-Stage4 |
1.421980E-02 |
| Stage2-vs-Stage3 |
4.451400E-01 |
| Stage2-vs-Stage4 |
4.879400E-01 |
| Stage3-vs-Stage4 |
9.384000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.568700E-04 |
| Normal-vs-AfricanAmerican |
1.095490E-03 |
| Normal-vs-Asian |
8.004400E-01 |
| Caucasian-vs-AfricanAmerican |
5.603000E-01 |
| Caucasian-vs-Asian |
3.034400E-01 |
| AfricanAmerican-vs-Asian |
1.948360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.241100000002E-05 |
| Normal-vs-Female |
1.707910E-02 |
| Male-vs-Female |
1.049860E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.050800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.195900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.024020E-04 |
| Normal-vs-Age(81-100Yrs) |
3.563800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.430000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.656400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.205000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.620200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.829800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.704800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.941800E-01 |
| Normal-vs-Grade 2 |
8.058300E-02 |
| Normal-vs-Grade 3 |
1.32269999952861E-07 |
| Normal-vs-Grade 4 |
2.34439999999836E-05 |
| Grade 1-vs-Grade 2 |
3.998200E-01 |
| Grade 1-vs-Grade 3 |
7.620500E-03 |
| Grade 1-vs-Grade 4 |
2.737900E-02 |
| Grade 2-vs-Grade 3 |
3.52350000000223E-05 |
| Grade 2-vs-Grade 4 |
9.231100E-04 |
| Grade 3-vs-Grade 4 |
3.006800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.999180E-01 |
| Normal-vs-ccB subtype |
6.24819999999193E-05 |
| ccA subtype-vs-ccB subtype |
4.1512999999993E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.117740E-03 |
| Normal-vs-N1 |
7.315500E-03 |
| N0-vs-N1 |
2.671200E-01 |
|
|
